abstract: Pancreatic cancer and a novel MSH2 germline alteration

CONCLUSIONS:

The MSH2 P349L may increase the risk for pancreatic cancer beyond the usual mutations in DNA mismatch repair genes; however, studies of additional families with the identical missense alteration are needed to confirm this initial impression.